These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6182407)

  • 21. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion.
    Slotman GJ; Machiedo GW; Casey KF; Lyons MJ
    Surgery; 1982 Jul; 92(1):93-9. PubMed ID: 7046123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia.
    Lefer AM; Ogletree ML; Smith JB; Silver MJ; Nicolaou KC; Barnette WE; Gasic GP
    Science; 1978 Apr; 200(4337):52-4. PubMed ID: 345441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of hemodynamic and respiratory effects of PGI2 in the pig.
    Clement MG; Triulzi MO; Maggi GC; Aguggini G
    Prostaglandins Med; 1980 Nov; 5(5):323-35. PubMed ID: 7005921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of PGI2 on canine renal function and hemodynamics.
    Gerber JG; Nies AS; Friesinger GC; Gerkens JF; Branch RA; Oates JA
    Prostaglandins; 1978 Oct; 16(4):519-28. PubMed ID: 364549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prostacyclin on hepatic vasculature and metabolism of renin in conscious dogs.
    Echtenkamp SF; Davis JO; Freeman RH; Dietz JR; Villarreal D
    Am J Physiol; 1982 Oct; 243(4):H584-9. PubMed ID: 6751098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic and metabolic effects of prostacyclin after coronary bypass surgery.
    Chelly J; Fabiani JN; Chahine R; Tricot AM; Carpentier A; Passelecq J; Dubost C
    Circulation; 1982 Aug; 66(2 Pt 2):I45-9. PubMed ID: 7044613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracoronary infusion of prostaglandin I2 attenuates arterial baroreflex control of heart rate in conscious dogs.
    Panzenbeck MJ; Tan W; Hajdu MA; Zucker IH
    Circ Res; 1988 Nov; 63(5):860-8. PubMed ID: 3052904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
    Welte M; Zwissler B; Habler O; Kleen M; Messmer K
    Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of prostacyclin (prostaglandin I2) in conscious ponies.
    Moore JN; Garner HE; Shapland JE; Roberts MC
    Am J Vet Res; 1982 Jul; 43(7):1128-31. PubMed ID: 7049019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prostacyclin on coronary hemodynamics at rest and in response to cold pressor testing in patients with angina pectoris.
    Ganz P; Gaspar J; Colucci WS; Barry WH; Mudge GH; Alexander RW
    Am J Cardiol; 1984 Jun; 53(11):1500-4. PubMed ID: 6375336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of myocardial protection with prostacyclin during cardiac arrest.
    Vincent JL; Domb M; Goldstein J; Lignian H; Van Belle J
    Prostaglandins Leukot Med; 1986 Sep; 24(1):87-92. PubMed ID: 3532136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of PGI2 and PGE1 on coronary and systemic hemodynamics and coronary arterial cyclic nucleotide levels in dogs.
    Ito T; Ogawa K; Enomoto I; Hashimoto H; Kai I; Satake T
    Adv Prostaglandin Thromboxane Res; 1980; 7():641-6. PubMed ID: 6245569
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
    Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
    Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular responses to PGI2 (prostacyclin) in the dog.
    Fitzpatrick TM; Alter I; Corey EJ; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1978 Feb; 42(2):192-4. PubMed ID: 340081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.